These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3475036)

  • 41. The comparative pharmacokinetics of five quinolones.
    Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():71-81. PubMed ID: 3468102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An evaluation of pelvic tissue concentrations after oral administration of enoxacin.
    Bates SA; Elder MG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():79-85. PubMed ID: 3162905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative trials of doxycycline versus amoxicillin, cephalexin and enoxacin in bacterial infections in chronic bronchitis and asthma.
    Chodosh S; Tuck J; Pizzuto D
    Scand J Infect Dis Suppl; 1988; 53():22-8. PubMed ID: 3047855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Penetration of roxithromycin in bronchial secretions.
    De Rose V; Ferrara A; Mangiarotti P; Nonis A; Bertoletti R; Gialdroni Grassi G
    Int J Clin Pharmacol Res; 1988; 8(2):107-10. PubMed ID: 3378852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro antibacterial activity of enoxacin (CI-919).
    Fernandes CJ; Munro R; Toohey M; Shanker S; Mallon R; Daley D; Harland GS; Stevens DA; Wilson RD; Ackerman VP
    Pathology; 1986 Apr; 18(2):240-2. PubMed ID: 3093961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid.
    Nakamura S; Minami A; Katae H; Inoue S; Yamagishi J; Takase Y; Shimizu M
    Antimicrob Agents Chemother; 1983 May; 23(5):641-8. PubMed ID: 6575721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enoxacin distribution in human tissues after multiple oral administration.
    Malmborg AS; Rannikko S
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():57-60. PubMed ID: 3162902
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Bronchopulmonary penetration of enoxacin].
    Loos U; Sörgel F; Marklein G; Kraeft H
    Infection; 1989; 17 Suppl 1():S23-4. PubMed ID: 2807559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enoxacin therapy for severe pleuro-pulmonary infections.
    Thadepalli H; Mathai D; Bansal MB; Chuah SK
    J Assoc Physicians India; 1991 Oct; 39(10):747-9. PubMed ID: 1816197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dirithromycin concentrations in bronchial mucosa and secretions.
    Leroyer C; Muller-Serieys C; Quiot J; Benhamou D; Clavier J; Bergogne-Bérézin E
    Respiration; 1998; 65(5):381-5. PubMed ID: 9782221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Penetration of cefotaxime into bronchial secretions].
    Bergogne-Berezin E; Morel C; Pierre J; Monrocq N; Dournovo P; Benard Y
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):501-5. PubMed ID: 6289226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [New oral quinolone compounds in chronic bronchitis].
    Davies BI; Maesen FP; Teengs JP; Baur C
    Infection; 1986; 14 Suppl 1():S73-8. PubMed ID: 2937739
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of food on enoxacin absorption.
    Somogyi AA; Bochner F; Keal JA; Rolan PE; Smith M
    Antimicrob Agents Chemother; 1987 Apr; 31(4):638-9. PubMed ID: 3475034
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Penetration of cefsulodin into bronchial secretions.
    Bergogne-Berezin E; Berthelot G; Safran D; Even P; Kafe H
    Chemotherapy; 1984; 30(4):205-10. PubMed ID: 6744972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1983 Nov; 24(5):754-63. PubMed ID: 6229216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of ethylenediaminetetraacetic acid and gentamicin on the antibacterial activity of pyridone carboxylic acid derivatives against gram-negative bacilli.
    Miyake Y; Mitsui K; Suginaka H
    J Antimicrob Chemother; 1986 Mar; 17(3):327-32. PubMed ID: 3084441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The penetration of macrolides into bronchial secretions.
    Pierre J; Bergogne-Berezin E; Kafe H; Dournovo P
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():217-20. PubMed ID: 4055550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low frequency of bacterial resistance to enoxacin in vitro and in experimental pneumonia.
    Scribner RK; Welch DF; Marks MI
    J Antimicrob Chemother; 1985 Nov; 16(5):597-603. PubMed ID: 3865924
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [In vitro activity of new quinolones against nonfermenters and references to sensitivity tests].
    Grimm H
    Infection; 1986; 14 Suppl 3():S191-5. PubMed ID: 3093387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Penetration of antimicrobial agents into bronchial secretions.
    Wong GA; Pierce TH; Goldstein E; Hoeprich PD
    Am J Med; 1975 Aug; 59(2):219-23. PubMed ID: 1155479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.